• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病矿物质与骨异常中血管钙化的发病机制:骨骼与血管系统之间的联系

The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.

作者信息

Hruska Keith A, Mathew Suresh, Lund Richard J, Memon Imran, Saab Georges

机构信息

Department of Pediatrics, Division of Nephrology, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

Semin Nephrol. 2009 Mar;29(2):156-65. doi: 10.1016/j.semnephrol.2009.01.008.

DOI:10.1016/j.semnephrol.2009.01.008
PMID:19371806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2758096/
Abstract

Considerable scientific progress in the pathogenesis of vascular calcification that has accrued in recent years is reviewed in this article. Factors regulating mesenchymal cell differentiation and their role in the neointimal calcification of atherosclerosis and the vascular media calcification observed in chronic kidney disease and diabetes are discussed, as is the role of bone regulatory proteins in bone mineralization and vascular calcification. This includes recent studies related to fetuin-A, and the discovery of a new circulating hormone involved in regulating phosphate homeostasis and sensing skeletal hydroxyapatite precipitation. Finally, the relationship between skeletal mineralization and vascular mineralization is discussed in terms of their links, especially through serum phosphate concentrations.

摘要

本文综述了近年来在血管钙化发病机制方面取得的重大科学进展。讨论了调节间充质细胞分化的因素及其在动脉粥样硬化新内膜钙化以及慢性肾病和糖尿病中观察到的血管中层钙化中的作用,还讨论了骨调节蛋白在骨矿化和血管钙化中的作用。这包括与胎球蛋白-A相关的最新研究,以及一种参与调节磷酸盐稳态和感知骨骼羟基磷灰石沉淀的新循环激素的发现。最后,从骨骼矿化和血管矿化的联系,特别是通过血清磷酸盐浓度的联系方面,讨论了它们之间的关系。

相似文献

1
The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.慢性肾脏病矿物质与骨异常中血管钙化的发病机制:骨骼与血管系统之间的联系
Semin Nephrol. 2009 Mar;29(2):156-65. doi: 10.1016/j.semnephrol.2009.01.008.
2
Vascular calcification in ESRD: Another cloud appears in the perfect storm--but highlights a silver lining?
Kidney Int. 2004 Dec;66(6):2467-8. doi: 10.1111/j.1523-1755.2004.66095.x.
3
[Experimental study of the mechanism for vascular calcification in chronic kidney disease].[慢性肾脏病血管钙化机制的实验研究]
Verh K Acad Geneeskd Belg. 2008;70(4):285-303.
4
The making of a bone in blood vessels: from the soft shell to the hard bone.血管中骨的形成:从软壳到硬骨。
Kidney Int. 2007 Sep;72(5):533-4. doi: 10.1038/sj.ki.5002440.
5
Pathogenesis of vascular calcification in dialysis patients.透析患者血管钙化的发病机制。
Clin Exp Nephrol. 2005 Dec;9(4):265-270. doi: 10.1007/s10157-005-0385-4.
6
Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?双膦酸盐可预防实验性血管钙化:治疗骨骼以治愈血管?
Kidney Int. 2006 Nov;70(9):1537-8. doi: 10.1038/sj.ki.5001899.
7
Extracellular matrix calcification in chronic kidney disease.慢性肾脏病中的细胞外基质钙化。
Curr Opin Nephrol Hypertens. 2011 Jul;20(4):360-8. doi: 10.1097/MNH.0b013e3283479330.
8
Mechanisms of vascular calcification.血管钙化的机制。
Adv Chronic Kidney Dis. 2007 Jan;14(1):54-66. doi: 10.1053/j.ackd.2006.10.007.
9
Vascular calcification and disordered mineral metabolism in dialysis patients.透析患者的血管钙化与矿物质代谢紊乱
Semin Dial. 2007 Mar-Apr;20(2):139-43. doi: 10.1111/j.1525-139X.2007.00261.x.
10
Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review.慢性肾脏病和终末期肾病患者冠状动脉血管钙化的决定因素:一项系统综述
J Nephrol. 2004 Mar-Apr;17(2):205-15.

引用本文的文献

1
Application of artificial intelligence to chronic kidney disease mineral bone disorder.人工智能在慢性肾脏病矿物质和骨异常中的应用。
Clin Kidney J. 2024 Jun 6;17(6):sfae143. doi: 10.1093/ckj/sfae143. eCollection 2024 Jun.
2
CDK1 inhibition reduces osteogenesis in endothelial cells in vascular calcification.CDK1 抑制可减少血管钙化中内皮细胞的成骨作用。
JCI Insight. 2024 Mar 8;9(5):e176065. doi: 10.1172/jci.insight.176065.
3
Association of Dietary Potassium Intake With Abdominal Aortic Calcification and Pulse Pressure in US Adults.

本文引用的文献

1
CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas.慢性肾脏病会加速动静脉内瘘中新生内膜增生的发展。
J Am Soc Nephrol. 2009 Jun;20(6):1236-45. doi: 10.1681/ASN.2007121312. Epub 2009 May 7.
2
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.成纤维细胞生长因子23与接受血液透析患者的死亡率
N Engl J Med. 2008 Aug 7;359(6):584-92. doi: 10.1056/NEJMoa0706130.
3
The mechanism of phosphorus as a cardiovascular risk factor in CKD.慢性肾脏病中磷作为心血管危险因素的机制。
美国成年人膳食钾摄入量与腹主动脉钙化和脉压的关系。
J Ren Nutr. 2023 Sep;33(5):657-665. doi: 10.1053/j.jrn.2023.06.003. Epub 2023 Jun 10.
4
Focusing on Phosphorus Loads: From Healthy People to Chronic Kidney Disease.聚焦磷负荷:从健康人群到慢性肾脏病。
Nutrients. 2023 Feb 28;15(5):1236. doi: 10.3390/nu15051236.
5
The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart.胎球蛋白-A 在非酒精性脂肪性肝病中的作用演变:从肝脏到心脏的概述。
Int J Mol Sci. 2021 Jun 21;22(12):6627. doi: 10.3390/ijms22126627.
6
Shifting osteogenesis in vascular calcification.血管钙化中的骨生成转变。
JCI Insight. 2021 May 24;6(10):143023. doi: 10.1172/jci.insight.143023.
7
Activation of the mTORC1 pathway by inflammation contributes to vascular calcification in patients with end-stage renal disease.炎症激活 mTORC1 通路导致终末期肾病患者的血管钙化。
J Nephrol. 2019 Feb;32(1):101-110. doi: 10.1007/s40620-018-0486-2. Epub 2018 May 14.
8
Safety of Low-calcium Dialysate and its Effects on Coronary Artery Calcification in Patients Undergoing Maintenance Hemodialysis.维持性血液透析患者使用低钙透析液的安全性及其对冠状动脉钙化的影响。
Sci Rep. 2018 Apr 13;8(1):5941. doi: 10.1038/s41598-018-24397-w.
9
Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients.肾移植患者冠状动脉钙化的长期进展独立于经典危险因素、C反应蛋白和甲状旁腺激素。
Cardiorenal Med. 2017 Oct;7(4):284-294. doi: 10.1159/000475999. Epub 2017 Jul 13.
10
Vascular calcification and cardiac function according to residual renal function in patients on hemodialysis with urination.血液透析伴排尿患者的血管钙化和心脏功能与残余肾功能的关系
PLoS One. 2017 Sep 27;12(9):e0185296. doi: 10.1371/journal.pone.0185296. eCollection 2017.
J Am Soc Nephrol. 2008 Jun;19(6):1092-105. doi: 10.1681/ASN.2007070760. Epub 2008 Apr 16.
4
Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy.碳酸司维拉姆治疗可逆转慢性肾脏病中的动力缺乏性骨病并减少血管钙化。
J Am Soc Nephrol. 2007 Jan;18(1):122-30. doi: 10.1681/ASN.2006050490. Epub 2006 Dec 20.
5
Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process.成纤维细胞生长因子23基因敲除小鼠中的早衰样表型是一个由维生素D介导的过程。
FASEB J. 2006 Apr;20(6):720-2. doi: 10.1096/fj.05-5432fje. Epub 2006 Jan 25.
6
Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome.在慢性肾病和代谢综合征的动物模型中,低转换型骨营养不良和血管钙化可通过骨骼合成代谢得到改善。
J Am Soc Nephrol. 2005 Apr;16(4):917-28. doi: 10.1681/ASN.2004100835. Epub 2005 Mar 2.
7
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.对Fgf23进行靶向消融表明FGF23在磷酸盐和维生素D代谢中具有重要的生理作用。
J Clin Invest. 2004 Feb;113(4):561-8. doi: 10.1172/JCI19081.
8
Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model.在肾切除模型中用骨形态发生蛋白-7成功治疗动力缺失性骨病
J Am Soc Nephrol. 2004 Feb;15(2):359-69. doi: 10.1097/01.asn.0000109671.99498.08.
9
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification.核因子κB受体激活剂配体和骨保护素调节主动脉瓣钙化。
J Mol Cell Cardiol. 2004 Jan;36(1):57-66. doi: 10.1016/j.yjmcc.2003.09.015.
10
Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy.
Semin Nephrol. 2004 Jan;24(1):25-38. doi: 10.1053/j.semnephrol.2003.08.010.